The outcome of the study revealed other interesting associations, too.

Researchers say the blood test could help identify people who may need further screening long before symptoms appear.

A blood test was able to predict the risk of dementia in women up to 25 years before symptoms appear, according to a new study ...

Researchers have identified a blood marker that could help detect dementia risk in women decades before symptoms begin, potentially transforming early prevention strategies.

A simple blood test identified women at higher risk for dementia up to 25 years before symptoms appeared. Higher levels of ...

A long-term study of 2,766 women in the Women’s Health Initiative Memory Study found that higher baseline plasma p-tau217 levels were associated with a greater risk of developing mild cognitive ...

Researchers say elevated p-tau217 levels in older women were strongly linked to future dementia, raising hopes for earlier ...

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.

Experts in the US found that higher levels of a protein called p-tau217 were an accurate predictor of people developing cognitive problems and dementia.

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.